University of Minnesota
University of Minnesota
Minneapolis, Minnesota, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma | mucosal melanoma | Active, not recruiting | Phase 2 | 2022-12-09 | NCT03241186 |